Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction

International Heart Journal

Volumn 50, Issue 4, 2009, Pages 407-419

  Sakr, Sherif A ^a   Abbas, Tarek M ^b   Amer, Maged Z ^a   Dawood, Eid M ^a   El Shahat, Nader ^a   Abdel Aal, Ibraheim A ^a   Ramadan, Mahmoud M ^a,c  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

C reactive protein; Flow mediated dilatation; Syndrome X

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID; LIPID;

ADULT; ANGIOCARDIOGRAPHY; ANKLE BRACHIAL INDEX; ARTICLE; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; EXERCISE TEST; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYNDROME X; THORAX PAIN; URIC ACID BLOOD LEVEL; BLOOD; BLOOD FLOW; CASE CONTROL STUDY; COHORT ANALYSIS; ECHOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ADULT; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPIDS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; REGIONAL BLOOD FLOW; URIC ACID; VASODILATION;

EID: 70349264299     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.50.407     Document Type: Article

References (38)

1. Proudfit WL, Shirley EK, Sones FM Jr, et al. Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients. Circulation 1966; 33: 901-10.
2. Kemp HG, Kronmal RA, Vlietstra RE, Frye RL. Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol 1986; 7: 479-83.
3. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973; 32: 375-6.
4. Beltrame JF. Advances in understanding the mechanisms of angina pectoris in cardiac syndrome X. Eur Heart J 2005; 26: 946-8.
5. Cannon RO 3rd, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation 1992; 85: 883-92.
6. Likoff W, Segal BL, Kasparian H. Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease. N Engl J Med 1967; 276: 1063-6.
7. Asbury EA, Collins P. Cardiac syndrome X. Int J Clin Pract 2000; 59: 1063-9. (Review)
8. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Eng J Med 1997; 336: 973-9.
9. Erdogan D, Gullu H, Caliskan M, et al. Coronary flow reserve and coronary microvascular functions are strongly related to serum uric acid concentrations in healthy adults. Coron Artery Dis 2006; 17: 7-14.
10. Yeboah J, Crouse JR, Hsu FC, Burke GL, Herrington DM. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation 2007; 115: 2390-7.
11. Hurst JW, Logue RB. The Heart. 2nd ed. New York: McGraw Hill Book Company; 1970.
12. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004; 90: 457-63. (Review)
13. Cannon RO 3rd, Epstein SE. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988; 61: 1338-43. (Review)
14. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997; 18: 60-8.
15. Lanza GA, Sestito A, Cammarota G, et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 2004; 94: 40-4.
16. Cosín-Sales J, Pizzi C, Brown S, Kaski JC. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 2003; 41: 1468-74.
17. Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 2003; 24: 1999-2005.
18. Rosenson RS. Statin therapy: new therapy for cardiac microvascular dysfunction. Eur Heart J 2003; 24: 1993-4.
19. Pizzi C, Manfrini O, Fontana F, Bugiardini R. Angiotensin-converting enzyme inhibitor and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac syndrome X: role of superoxide dismutase activity. Circulation 2004; 109: 53-8.
20. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation 2004; 109: II2-10. (Review)
21. Pearson TA, Mensah GA, Hong Y, Smith SC Jr.; CDC; AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation 2004; 110: e543-4.
22. Kuo LT, Yang NI, Cherng WJ, et al. Serum interleukin-6 levels, not genotype, correlate with coronary plaque complexity. Int Heart J 2008; 49: 391-402.
23. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17: 1121-7.
24. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
25. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation 1997; 96: 778-84.
26. Alderman MH. Uric acid and cardiovascular risk. Curr Opin Pharmacol 2002; 2: 126-30. (Review)
27. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 31: 7-13.
28. Niskanen LK, Laaksonen DE, Nyyssönen K, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 2004; 164: 1546-51.
29. Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol 1996; 6: 331-40.
30. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-90. (Review)
31. Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002; 105: 2619-24.
32. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 2004; 109: 2818-25. (Review)
33. Tamakoshi K, Yatsuya H, Kondo T, et al. The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low grade inflammatory state. Int J Obes Relat Metab Disord 2003; 27: 443-9.
34. Fathi R, Haluska B, Isbel N, Short L, Marwick TH. The relative importance of vascular structure and function in predicting cardiovascular events. J Am Coll Cardiol 2004; 43: 616-23.
35. Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol 2003; 42: 1037-43.
36. Meyer B, Mörtl D, Strecker K, et al. Flow-mediated vasodilation predicts outcomes in patients with chronic heart failure: comparison with B-type natriuretic peptide. J Am Coll Cardiol 2005; 46: 1011-8.
37. Frick M, Suessenbacher A, Alber HF, et al. Prognostic value of brachial artery endothelial function and wall thickness. J Am Coll Cardiol 2005; 46: 1006-10.
38. Shimbo D, Grahame-Clarke C, Miyake Y, et al. The association between endothelial dysfunction and cardiovascular outcomes in a population-based multi-ethnic cohort. Atherosclerosis 2007; 192: 197-203.